Paloma Gijón - Academia.edu (original) (raw)

Uploads

Papers by Paloma Gijón

Research paper thumbnail of Tuberculosis Outbreak in a Nursery School: A Process Developed During Three Years

Open Forum Infectious Diseases, 2016

Research paper thumbnail of Fungaemia caused by rare yeasts: incidence, clinical characteristics and outcome over 10 years

The Journal of antimicrobial chemotherapy, Jan 5, 2017

Research paper thumbnail of Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp

Medical Mycology, 2008

We studied 75 patients with non-hematological conditions from whom Aspergillus spp. were recovere... more We studied 75 patients with non-hematological conditions from whom Aspergillus spp. were recovered from clinical specimens during the period March 2003 to August 2006. The patients were classified according to EORTC criteria and the presence of galactomannan (Platelia Aspergillus) in their sera was evaluated. Ten of these patients (13.3%) had proven or probable invasive aspergillosis, i.e., chronic obstructive pulmonary disease in five (50%), HIV infection in one (10%), lymphoma in one (10%), liver transplant in one (10%), solid malignancies in one (10%), and corticosteroid treatment in one (10%). The sensitivity, specificity, and positive and negative predictive values for the detection of galactomannan, using cut-offs of > or =0.5 ng/ml and > or =1 ng/ml were 60%/50%, 89.23%/100%, 46.15%/100%, and 93.55%/92.86% (p=0.001 and p<0.001), respectively. The determination of galactomannan in the sera of non-neutropenic patients could prove to be a useful microbiological finding when diagnosing invasive aspergillosis.

Research paper thumbnail of False-positive Aspergillus Antigenemia Due to Blood Product Conditioning Fluids

Clinical Infectious Diseases, 2012

Research paper thumbnail of Limitación del esfuerzo terapéutico

... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: C... more ... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: Cera, 1994: 431-458. 14. ... Madrid: Nóesis 1996; 355-368. 25. Callahan D. Terminating treatment: age as a standard. Hastings Center Report 1987; 17 (6): 21-25. Pubmed 26. ...

Research paper thumbnail of Limitation of therapeutic effort

Research paper thumbnail of Limitación del esfuerzo terapéutico

Medicina Clínica, 2001

... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: C... more ... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: Cera, 1994: 431-458. 14. ... Madrid: Nóesis 1996; 355-368. 25. Callahan D. Terminating treatment: age as a standard. Hastings Center Report 1987; 17 (6): 21-25. Pubmed 26. ...

Research paper thumbnail of Tuberculosis Outbreak in a Nursery School: A Process Developed During Three Years

Open Forum Infectious Diseases, 2016

Research paper thumbnail of Fungaemia caused by rare yeasts: incidence, clinical characteristics and outcome over 10 years

The Journal of antimicrobial chemotherapy, Jan 5, 2017

Research paper thumbnail of Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp

Medical Mycology, 2008

We studied 75 patients with non-hematological conditions from whom Aspergillus spp. were recovere... more We studied 75 patients with non-hematological conditions from whom Aspergillus spp. were recovered from clinical specimens during the period March 2003 to August 2006. The patients were classified according to EORTC criteria and the presence of galactomannan (Platelia Aspergillus) in their sera was evaluated. Ten of these patients (13.3%) had proven or probable invasive aspergillosis, i.e., chronic obstructive pulmonary disease in five (50%), HIV infection in one (10%), lymphoma in one (10%), liver transplant in one (10%), solid malignancies in one (10%), and corticosteroid treatment in one (10%). The sensitivity, specificity, and positive and negative predictive values for the detection of galactomannan, using cut-offs of > or =0.5 ng/ml and > or =1 ng/ml were 60%/50%, 89.23%/100%, 46.15%/100%, and 93.55%/92.86% (p=0.001 and p<0.001), respectively. The determination of galactomannan in the sera of non-neutropenic patients could prove to be a useful microbiological finding when diagnosing invasive aspergillosis.

Research paper thumbnail of False-positive Aspergillus Antigenemia Due to Blood Product Conditioning Fluids

Clinical Infectious Diseases, 2012

Research paper thumbnail of Limitación del esfuerzo terapéutico

... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: C... more ... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: Cera, 1994: 431-458. 14. ... Madrid: Nóesis 1996; 355-368. 25. Callahan D. Terminating treatment: age as a standard. Hastings Center Report 1987; 17 (6): 21-25. Pubmed 26. ...

Research paper thumbnail of Limitation of therapeutic effort

Research paper thumbnail of Limitación del esfuerzo terapéutico

Medicina Clínica, 2001

... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: C... more ... 13. Romeo Casabona CM. El derecho y la bioética ante los límites de la vida humana. Madrid: Cera, 1994: 431-458. 14. ... Madrid: Nóesis 1996; 355-368. 25. Callahan D. Terminating treatment: age as a standard. Hastings Center Report 1987; 17 (6): 21-25. Pubmed 26. ...

Log In